{"id":"W4379093489","doi":"10.57264/cer-2023-0016","title":"Comparative efficacy of therapies for relapsing multiple sclerosis: a systematic review and network meta-analysis","year":2023,"lang":"en","type":"review","venue":"Journal of Comparative Effectiveness Research","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":52,"is_retracted":false,"has_abstract":true,"ca_institutions":"EVERSANA (Canada)","funders":"","keywords":"Medicine; Ofatumumab; Alemtuzumab; Ocrelizumab; Natalizumab; Internal medicine; Placebo; Multiple sclerosis; Lipoarabinomannan; Oncology; Rituximab; Disease; Tuberculosis; Immunology; Alternative medicine; Pathology; Lymphoma","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","metaepi_broad"],"consensus_categories":[],"category_scores_codex":[0.0250095,0.0008701694,0.03329588,0.002355737,0.0004680311,0.0001175823,0.0007227767,0.0002746206,0.00003097477],"category_scores_gemma":[0.006839192,0.0005017773,0.007016021,0.005716523,0.0009739356,0.0002083235,0.0004158065,0.001966875,0.00001447056],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004828802,"about_ca_system_score_gemma":0.0008378057,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00002177884,"about_ca_topic_score_gemma":0.00002500507,"domain_scores_codex":[0.9769212,0.01558813,0.003422416,0.0007456013,0.0024278,0.0008948697],"domain_scores_gemma":[0.9192491,0.07076028,0.002916728,0.0008341545,0.005866649,0.000373066],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","study_design_scores_codex":[0.0004537702,0.0002822363,0.0000134379,0.6203665,0.3769443,0.000009801751,0.0005751818,0.00006913974,0.00001254679,0.00003525796,0.0005302657,0.0007075149],"study_design_scores_gemma":[0.001645555,0.001499896,0.0005581412,0.4757981,0.5170714,0.00003251599,0.0003797503,0.0001795053,0.000019924,0.00004514884,0.00243853,0.0003314839],"study_design_candidate":"systematic_review","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.00008915905,0.9815004,0.0008477793,0.000073166,0.00007291204,0.01721407,0.0001438734,0.00002046164,0.00003819569],"genre_scores_gemma":[0.005109358,0.9907178,0.0008348675,0.000009408754,0.0001793904,0.002923776,0.00003392135,0.00008293991,0.000108558],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.1445684,"threshold_uncertainty_score":0.9997434,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.7093580791148476,"score_gpt":0.5626411172863962,"score_spread":0.1467169618284514,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}